Key result
Upregulated NOD1 drives atrial remodeling and calcium dysregulation in heart failure via CaMKII-RyR2 activation.
Why the study?
Does NOD1 inhibition prevent atrial remodeling and Ca2+ dysregulation in heart failure?
Does NOD1 inhibition prevent atrial remodeling and Ca2+ dysregulation in heart failure?
The NOD1-CaMKII-RyR2 axis is a key mechanism linking innate immune activation to atrial myopathy in heart failure, highlighting NOD1 as a potential therapeutic target.
NOD1 may drive atrial remodeling in heart failure; leaves open whether targeted inhibition alters outcomes.
Heart failure (HF)-associated atrial myopathy is driven by complex and poorly understood mechanisms. Emerging evidence suggests that innate immune components contribute to atrial remodeling, yet the role of nucleotide-binding oligomerization domain-containing protein 1 (NOD1) receptors remains unclear. Methods: -S2814A mice. Proteomic, phosphoproteomic, transcriptomic, and Ca²⁺ imaging analyses were performed across experimental systems. Results: -S2814A mice. Human atrial transcriptomic analysis confirmed enrichment of inflammatory, Ca²⁺-signaling, and extracellular matrix remodeling pathways in HF. Increased CaMKII phosphorylation in human atrial myocardium further corroborated the translational relevance of the NOD1-CaMKII-RyR2 axis. Conclusions: These findings identify the NOD1-CaMKII-RyR2 axis as a cardiomyocyte-centered mechanism linking innate immune activation to atrial Ca²⁺ dysregulation and structural remodeling in HF, establishing NOD1 as a molecular indicator of atrial myopathy burden and a mechanism-based therapeutic target.
No takes yet. Share an insight, caveat, or question.
Gil-Fernández et al. (2026) studied Heart failure-associated atrial myopathy (n=78). Heart failure (NOD1 upregulation) vs. Non-failing controls was evaluated on NOD1 protein expression and atrial structural/functional remodeling. NOD1 is markedly upregulated in the atrial myocardium of heart failure patients and drives atrial structural remodeling and calcium dysregulation through the CaMKII-RyR2 axis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: